Premium Only Content
This video is only available to Rumble Premium subscribers. Subscribe to
enjoy exclusive content and ad-free viewing.

Alzheimer's Therapy Drug: Should We Pay $56,000 to Slow the Loss of Mom's Mind?
4 years ago
1.04K
Aduhelm sparks controversy as a therapy drug for Alzheimer's patients that attacks amyloid plaques in the brain, and slows the decline of memory and problem-solving by about 25% over time. It's not a cure, and it can't even restore lost mental capabilities. Now that the FDA has fast-tracked approval, should American taxpayers cover the $56,000/year per patient cost for relative minor results?
Scott Ott, Stephen Green and Bill Whittle create 240 new episodes of Right Angle annually, thanks to our Members. Join us now at https://BillWhittle.com
Loading 19 comments...
-
10:07
Bill Whittle: Conservative Opinion | Humor
1 month ago $3.45 earnedHunter Biden Checks In
2.84K5 -
1:21:51
TheDAMpodcast
4 years ago $0.06 earnedWhen and why should anyone take therapy?
1071 -
3:56
NEWSMAX
4 years agoFDA APPROVES NEW ALZHEIMER'S DRUG
1.9K23 -
1:11
IOL-IndependentOnline
4 years ago $0.01 earnedFirst patient receives controversial Biogen Alzheimer's drug
37 -
1:56
KGUN
4 years agoHikers should keep heat safety in mind
2 -
LIVE
THOUGHTCAST With Jeff D.
1 hour agoLabor Day Weekend FORTNITE With THOUGHTCAST Jeff & the squad
62 watching -
Rallied
4 hours ago $2.24 earnedSolo Challenges All Day
26.5K1 -
LIVE
iCheapshot
4 hours agoCall of Duty: Black Ops Campaign
32 watching -
4:39:16
Meisters of Madness
5 hours agoMadness in a Pod
6891 -
HELMETFIRE
1 hour ago🟢GAMING WITH FIRE EP9🟢
587